Literature DB >> 2878967

Variation in the expression of pili and outer membrane protein by Neisseria meningitidis during the course of meningococcal infection.

C R Tinsley, J E Heckels.   

Abstract

The occurrence of antigenic shift during meningococcal infection has been investigated by comparison of paired isolates obtained from the blood, cerebrospinal fluid or nasopharynx of patients. Isolates from any individual produced identical DNA 'fingerprints' and showed stability in expression of both class 2 outer membrane protein and an antigen common to pathogenic Neisseria, confirming their origin as a single strain. One of the four strains examined produced variants which differed in the molecular mass of their class 5 outer membrane proteins. Three of the strains produced pili containing the epitope recognized by monoclonal antibody SM1 and two of these gave rise to variants which expressed pili of differing subunit molecular masses. The two variants of the remaining strain produced pilins lacking the common epitope detected by antibody SM1 but radioimmune precipitation with polyclonal anti-pilus antiserum revealed that variation in the molecular mass of the pilin expressed also occurred with this second class of pili. Antigenic variation in expression of both class 5 outer membrane proteins and pili therefore appears to be a common occurrence during meningococcal infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878967     DOI: 10.1099/00221287-132-9-2483

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  29 in total

1.  Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.

Authors:  K A Jolley; L Appleby; J C Wright; M Christodoulides; J E Heckels
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo.

Authors:  O B Harrison; B D Robertson; S N Faust; M A Jepson; R D Goldin; M Levin; R S Heyderman
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 3.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

4.  Variation in expression of class 1 and class 5 outer membrane proteins during nasopharyngeal carriage of Neisseria meningitidis.

Authors:  J P Woods; J G Cannon
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 5.  Genetic mechanisms and biological implications of phase variation in pathogenic neisseriae.

Authors:  T F Meyer; J P van Putten
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

6.  Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant.

Authors:  Jeannette N Williams; Paul J Skipp; Holly E Humphries; Myron Christodoulides; C David O'Connor; John E Heckels
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

7.  Characterization of Neisseria meningitidis isolated by ribosomal RNA gene restriction patterns and restriction endonuclease digestion of chromosomal DNA.

Authors:  J Z Jordens; T H Pennington
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

Review 8.  Structure and function of pili of pathogenic Neisseria species.

Authors:  J E Heckels
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

9.  Molecular cloning and expression of Neisseria meningitidis class 1 outer membrane protein in Escherichia coli K-12.

Authors:  A K Barlow; J E Heckels; I N Clarke
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

10.  Activation of human dendritic cells is modulated by components of the outer membranes of Neisseria meningitidis.

Authors:  Tamara Al-Bader; Myron Christodoulides; John E Heckels; Judith Holloway; Amanda E Semper; Peter S Friedmann
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.